H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 110 Citations 91,130 500 World Ranking 425 National Ranking 279
Medicine D-index 139 Citations 84,747 478 World Ranking 689 National Ranking 415

Research.com Recognitions

Awards & Achievements

2003 - Fellow of the American Association for the Advancement of Science (AAAS)


What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

Michael A. Caligiuri mainly focuses on Immunology, Natural killer cell, Interleukin 21, Leukemia and Interleukin 12. His Immunology study frequently draws connections to adjacent fields such as Cancer research. His research in Natural killer cell intersects with topics in Lymphopoiesis and Receptor.

He has included themes like Cancer, Myeloid leukemia, Oncology and NPM1 in his Leukemia study. The Myeloid leukemia study which covers BAALC that intersects with Fms-Like Tyrosine Kinase 3. His research integrates issues of Monokine and Cell biology in his study of Interleukin 12.

His most cited work include:

  • Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. (11046 citations)
  • The biology of human natural killer-cell subsets. (2148 citations)
  • Innate or Adaptive Immunity? The Example of Natural Killer Cells (1717 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, Cancer research, Leukemia, Myeloid leukemia and Internal medicine. His study in Immunology is interdisciplinary in nature, drawing from both Natural killer cell and Interleukin 12. Michael A. Caligiuri combines subjects such as Innate immune system and Interleukin 15 with his study of Natural killer cell.

His Cancer research study integrates concerns from other disciplines, such as Haematopoiesis, Stem cell, T cell, Chronic myelogenous leukemia and microRNA. His Leukemia research incorporates themes from Cancer, Fms-Like Tyrosine Kinase 3, Myeloid, BAALC and NPM1. The study incorporates disciplines such as Genetics, Gene, MLL Partial Tandem Duplication, Molecular biology and Bone marrow in addition to Myeloid leukemia.

He most often published in these fields:

  • Immunology (46.01%)
  • Cancer research (36.63%)
  • Leukemia (25.69%)

What were the highlights of his more recent work (between 2016-2021)?

  • Cancer research (36.63%)
  • Immune system (13.37%)
  • Cell biology (16.32%)

In recent papers he was focusing on the following fields of study:

His main research concerns Cancer research, Immune system, Cell biology, Immunology and Cell. He has researched Cancer research in several fields, including T cell, Leukemia and Cutaneous T-cell lymphoma. His Immune system research is multidisciplinary, relying on both Cytotoxic T cell and Antigen.

As a member of one scientific family, he mostly works in the field of Cell biology, focusing on Granzyme B and, on occasion, Innate immune system. His Immunology study frequently links to related topics such as Natural killer cell. His Myeloid leukemia study incorporates themes from Myeloid, microRNA and Tandem exon duplication.

Between 2016 and 2021, his most popular works were:

  • The Broad Spectrum of Human Natural Killer Cell Diversity. (211 citations)
  • Ibrutinib treatment improves T cell number and function in CLL patients (140 citations)
  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

Cancer research, Antigen, Cell biology, Leukemia and Cell are his primary areas of study. The various areas that Michael A. Caligiuri examines in his Cancer research study include Cell culture, CD8, Cell killing and Interleukin 15. His Antigen research includes themes of Antibody, Immune system and Virology.

The concepts of his Cell biology study are interwoven with issues in Granzyme B, Transcription factor, Innate lymphoid cell and Functional profiling. His work deals with themes such as Myeloid and Myeloid leukemia, which intersect with Leukemia. His Natural killer cell research focuses on Immunology and how it relates to Cell growth.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

T. R. Golub;T. R. Golub;D. K. Slonim;P. Tamayo;C. Huard.
Science (1999)

14159 Citations

The biology of human natural killer-cell subsets.

Megan A Cooper;Todd A Fehniger;Michael A Caligiuri.
Trends in Immunology (2001)

3157 Citations

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Eric Vivier;David H. Raulet;Alessandro Moretta;Michael A. Caligiuri.
Science (2011)

2172 Citations

Human natural killer cells

Michael A. Caligiuri.
Blood (2008)

2044 Citations

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

Joseph F. Costello;Joseph F. Costello;Michael C. Frühwald;Michael C. Frühwald;Dominic J. Smiraglia;Laura J. Rush.
Nature Genetics (2000)

1696 Citations

Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

Megan A. Cooper;Todd A. Fehniger;Sarah C. Turner;Kenneth S. Chen.
Blood (2001)

1593 Citations

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

Muller Fabbri;Alessio Paone;Federica Calore;Roberta Galli.
Proceedings of the National Academy of Sciences of the United States of America (2012)

1186 Citations

Interleukin 15: biology and relevance to human disease

Todd A. Fehniger;Michael A. Caligiuri.
Blood (2001)

1141 Citations

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity

Todd A Fehniger;Megan A Cooper;Gerard J Nuovo;Marina Cella.
Blood (2003)

882 Citations

Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus.
Cancer Research (2001)

873 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michael A. Caligiuri

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 198

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 189

Eric Vivier

Eric Vivier

Aix-Marseille University

Publications: 141

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 127

Jeffrey S. Miller

Jeffrey S. Miller

University of Minnesota

Publications: 117

Todd R. Golub

Todd R. Golub

Harvard University

Publications: 116

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 109

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 108

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 100

Richard Stone

Richard Stone

Harvard University

Publications: 99

Guido Marcucci

Guido Marcucci

City Of Hope National Medical Center

Publications: 98

Hartmut Döhner

Hartmut Döhner

University of Ulm

Publications: 97

Clara D. Bloomfield

Clara D. Bloomfield

The Ohio State University

Publications: 95

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 92

Wolfgang Kern

Wolfgang Kern

Munich Leukemia Laboratory (Germany)

Publications: 90

Wolfgang Hiddemann

Wolfgang Hiddemann

Ludwig-Maximilians-Universität München

Publications: 89

Something went wrong. Please try again later.